Email Updates

You are here

Home

AVAC's Blog: P-Values

  • PrEP Stymied in Europe: What's the hold up?

    Europe is the birthplace of the smallpox vaccine and the Renaissance, among other treasures. So why can’t this continent that has brought forth such cornerstones of public health and flourishing civilization deliver oral PrEP, which already exists and is being successfully implemented in several countries?

    June 5, 2017
    PrEP
    Cindra Feuer

  • In the Face of Complex HIV Vaccine Research, the Ground is Ripe for Renewed Advocacy and Activism

    Good Participatory Practice and community voices are needed now more than ever in the HIV vaccine research arena.

    June 2, 2017
    Daisy Ouya
    Morenike Ukpong

  • VMMC: Progress to Date Gives Me Hope; Funding Commitments Give Me Chills!

    A presentation by the WHO earlier in the year brought good news about voluntary medical male circumcision (VMMC), telling a story of lives saved—many, many lives. But a new framework and ambitious targets, without similarly ambitious funding commitments, leaves advocate and AVAC staffer Angelo Kaggwa-Katumba with the chills.

    June 2, 2017
    Voluntary Medical Male Circumcision
    Angelo Kaggwa-Katumba

  • Trump's Budget Would Cut Promising Research and Live-Saving Interventions for HIV

    President Trump's 2018 budget request delivered to Congress would be a disaster for people living with HIV and for those at risk of HIV infection here in the US and around the world.

    May 24, 2017
    General
    AVAC

  • Advocacy in Uncertain Times: A call to action

    This year on HIV Vaccine Awareness Day, our core message is simple: no end without a vaccine; no vaccine without funding.

    May 16, 2017
    Antibody Related Research, HIV Vaccine
    AVAC

  • AVAC Statement on the Expanded Global Gag Rule

    The Trump Administration, in expanding the Global Gag Rule, has implemented a policy change endangering the lives of millions of adolescent girls and young women living in countries supported by US global health development aid. AVAC and our partners in Africa will do all that we can to help ensure that lifesaving programs and information for women and girls continue.

    May 15, 2017
    General
    AVAC

  • New Px Wire: Trial design in the era of PrEP

    Our new issue of Px Wire offers an advocate’s guide to some new types of biomedical prevention trial designs. You’ll find a handy summary of long-acting PrEP trials, a lexicon of key terms for the "post-placebo era", and a handy illustration for looking smart while you explain "double-dummy double-blind".

    May 11, 2017
    Antibody Related Research, PrEP
    AVAC

  • AVAC’s Month-Long Vaccine Immersion Continues: Webinar series, cheat sheets and more! 

    Join us in our month-long “deep dive” into the dynamic field of HIV vaccine research with the next installment in our HIV Vaccine Awareness Day webinar series coming up this Thursday. And read on for links to key resources, including quick references and recordings of our other webinars.

    May 2, 2017
    Antibody Related Research, HIV Vaccine
    AVAC

  • Webinar with WHO on hormonal contraception and HIV

    In this webinar, we were joined by Dr. James Kiarie, coordinator of the Human Reproduction Team at the World Health Organization. Dr. Kiarie presented new guidance from WHO on hormonal contraceptive eligibility for women at high risk of HIV.

    April 26, 2017
    Hormonal Contraceptives and HIV
    AVAC

  • CROI 2017: A View from My Seat at the Table

    Rob Newells, Executive Director for the AIDS Project of the East Bay, reports back on what caught his attention at the Conference on Retroviruses and Opportunistic Infections and his experience as one of very few African America attendees.

    April 24, 2017
    Antibody Related Research, Cure, PrEP
    Rob Newells

Pages

view more